Abstract
Purpose
To compare the efficacy and safety of fibrin glue and sutures for amniotic membrane transplantation after wide excision of primary pterygium.
Methods
Forty-three eyes of 37 patients underwent amniotic membrane transplantation for primary pterygium with a minimum follow-up period of six months. Twenty-three eyes of 18 patients underwent surgery with fibrin glue and 20 eyes of 19 patients underwent surgery with sutures. Recurrence rates, complications, operating time were evaluated.
Results
With a minimum of six-month of follow-up, fibrovascular tissue in the excised area, not invading the cornea (conjunctival recurrence), was noted in four eyes (17.4%) and fibrovascular tissue invading the cornea (corneal recurrence) was noted in two eyes (8.7%) in the fibrin glue group. Conjunctival recurrence was noted in five eyes (25%) and corneal recurrence was noted in one eye (5%) in the suture group. There was no significant difference in the recurrence rates between the two groups. Mean operating time in the fibrin glue group (25.2±3.5 minutes) was significantly shorter than in the suture group (40.5±3.6 minutes) (p=0.001, Students t-test). Complications included sub-amniotic membrane hemorrhage in three eyes (13%), and granuloma in one eye (4.3%) in the fibrin glue group, sub-amniotic membrane hemorrhage in four eyes (20%), granuloma in three eyes (15%), and wound dehiscence in one eye (5%) in the suture group.
References
1. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001; 119:695–706.
2. Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in pterygium and normal conjunctiva. Cornea. 2004; 23:67–70.
3. Solomon A, Grueterich M, Li DQ, et al. Overexpression of insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci. 2003; 44:573–80.
4. Di Girolamo N, McCluskey P, Lloyd A, et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000 Mar; 41:671–9.
5. Li DQ, Lee SB, Gunja-Smith Z, Liu Y, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001; 119:71–80.
6. Dushku N, Hatcher SL, Albert DM, Reid TW. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol. 1999; 117:1593–9.
7. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999; 128:280–7.
8. Tsai YY, Cheng YW, Lee H, et al. Oxidative DNA damage in pterygium. Mol Vis. 2005; 11:71–5.
9. Dadeya S, Malik KP, Gullian BP. Pterygium surgery: conjunctival rotation autograft versus conjunctival autograft. Ophthalmic Surg Lasers. 2002; 33:269–74.
10. Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997; 115:1235–40.
11. Al Fayez MF. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 2002; 109:1752–5.
12. Gris O, Guell JL, del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology. 2000; 107:270–3.
13. Shimazaki J, Yang HY, Tsubota K. Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers. 1996; 27:917–23.
14. Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol. 2002; 13:204–12.
15. Solomon A, Pires RT, Tseng SC. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108:449–60.
16. Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea. 2005; 24:141–50.
17. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997; 104:974–85.
18. Jurgenliemk-Schulz IM, Hartman LJ, Roesink JM, et al. Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys. 2004; 59:1138–47.
19. Liddy BS, Morgan JF. Triethylene thiophosphoramide (thio-tepa) and pterygium. Am J Ophthalmol. 1966; 61:888–90.
20. Segev F, Jaeger-Roshu S, Gefen-Carmi N, Assia EI. Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery. Cornea. 2003; 22:598–603.
21. Sharma A, Gupta A, Ram J, Gupta A. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000; 31:301–7.
22. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea. 2004; 23:458–63.
23. Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand. 2005; 83:298–301.
24. Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology. 2005; 112:667–71.
25. Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small incision approach to pterygium surgery. Br J Ophthalmol. 2004; 88:911–4.
26. Marticorena J, Rodriguez-Ares MT, Tourino R, et al. Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea. 2006; 25:34–6.
27. Hick S, Demers PE, Brunette I, et al. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 2005; 24:369–77.
28. Sharma A, Kaur R, Kumar S, et al. Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology. 2003; 110:291–8.
29. Pfister RR, Sommers CI. Fibrin sealant in corneal stem cell transplantation. Cornea. 2005; 24:593–8.
30. Velazquez AJ, Carnahan MA, Kristinsson J, et al. New dendritic adhesives for sutureless ophthalmic surgical procedures: in vitro studies of corneal laceration repair. Arch Ophthalmol. 2004; 122:867–70.
31. Refojo MF, Dohlman CH, Ahmad B, et al. Evaluation of adhesives for corneal surgery. Arch Ophthalmol. 1968; 80:645–56.
32. Webster RG Jr, Slansky HH, Refojo MF, et al. The use of adhesive for the closure of corneal perforations: report of two cases. Arch Ophthalmol. 1968; 80:705–9.
33. Cohen RA, McDonald MB. Fixation of conjunctival autografts with an organic tissue adhesive. Arch Ophthalmol. 1993; 111:1167–8.
34. Yoon KC, Heo H, Jeong IY, et al. The use of fibrin glue for conjunctival autotransplantation in pterygium. J Korean Ophthalmol Soc. 2006; 47:198–204.
35. Paek KU, Park HS, Kim YI. Ocular surface reconstruction with amniotic membrane transplantation in pterygium. J Korean Ophthalmol Soc. 1999; 40:1178–83.
36. Jang JH, Choi TH. The effect of amniotic membrane transplantation for pterygium excision. J Korean Ophthalmol Soc. 2005; 46:597–604.
Table 1.
Fibrin glue (23 eyes) | Suture (20 eyes) | p-value | |
---|---|---|---|
Age (years) (Mean±SD*) | 60.5±11.7 | 57.1±13.1 | 0.41† |
Sex (Male: Female) | 10:8 | 6:13 | 0.14‡ |
Follow-up (weeks) (Mean±SD*) | 28.4±2.8 | 26.9±2.6 | 0.10† |
Grade T2: Grade T3 (eyes) | 9:14 | 7:13 |